Apolipoprotein AI mimetic peptide CS-6253 increases the atherosclerotic lesion stability index independent of leukocyte abca1 in bone marrow-derived cells

Sekar, A.P., Snip, O.S., Hoekstra, M., Johansson, J.O., Eck, M.V. (2024). Apolipoprotein AI mimetic peptide CS-6253 increases the atherosclerotic lesion stability index independent of leukocyte abca1 in bone marrow-derived cells. https://doi.org/10.1016/j.atherosclerosis.2024.118430

Sekar, Andisyah Putri, et al.. "Apolipoprotein AI mimetic peptide CS-6253 increases the atherosclerotic lesion stability index independent of leukocyte abca1 in bone marrow-derived cells". CrossRef, 2024. doi:10.1016/j.atherosclerosis.2024.118430.

@article{sekar2024, author = {Andisyah Putri Sekar and Olga S.C. Snip and Menno Hoekstra and Jan O. Johansson and Miranda Van Eck}, title = {Apolipoprotein AI mimetic peptide CS-6253 increases the atherosclerotic lesion stability index independent of leukocyte abca1 in bone marrow-derived cells}, year = {2024}, journal = {CrossRef}, doi = {10.1016/j.atherosclerosis.2024.118430}, url = {https://doi.org/10.1016/j.atherosclerosis.2024.118430}, }

Apolipoprotein AI mimetic peptide CS-6253 increases the atherosclerotic lesion stability index independent of leukocyte abca1 in bone marrow-derived cells

Penulis (5)

Format Sitasi

Akses Cepat